Clinical Trials Browser

Phase 1 × INDUSTRY × Ovarian Epithelial Cancer Recurrent × Clear all

NCT02260544 2016-09-23

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Phase 1 Completed

Ovarian Epithelial Cancer Recurrent